The Experts below are selected from a list of 285 Experts worldwide ranked by ideXlab platform
P Deotale - One of the best experts on this subject based on the ideXlab platform.
-
unusual case reports tardive Oculogyric Crisis tardive syndromes
Indian Journal of Psychiatry, 2007Co-Authors: Vihang N Vahia, P M Naik, P DeotaleAbstract:We report, we believe for the first time in India, two cases of tardive Oculogyric Crisis in patients of schizophrenia, paranoid subtype (DSM IV code 295.30) during olanzapine therapy. Relevant data on this rare condition is discussed.
Kazuhiko Abe - One of the best experts on this subject based on the ideXlab platform.
-
psychiatric symptoms associated with Oculogyric Crisis a review of literature for the characterization of antipsychotic induced episodes
World Journal of Biological Psychiatry, 2006Co-Authors: Kazuhiko AbeAbstract:Antipsychotics have been found to induce recurrent psychotic episodes lasting minutes to hours, mostly accompanied by Oculogyric Crisis (OGC). To characterize this side effect, antipsychotic-induced and postencephalitic OGCs that were reported in the literature were compared to find out common characteristics of OGCs and their associated symptoms. Both postencephalitic and antipsychotic-induced OGCs were found to occur late in the day and at regular intervals, and were associated with autonomic symptoms such as profuse sweating, facial flushing, transitory hypertension and difficulty in micturition. They were often associated also with transient psychiatric episodes: visual hallucinations and illusions, auditory hallucinations, delusions, catatonic phenomena, obsessive thoughts and panic attacks. These (OGC) characteristics will be useful in recognizing antipsychotic-induced psychiatric episodes. The associated psychiatric episodes were noted to recur occasionally also without OGC in a few postencephalic ...
Tanja Franciskovic - One of the best experts on this subject based on the ideXlab platform.
-
p 294 Oculogyric Crisis unexpected side effect when using low doses of risperidone in adolescent patient
European Psychiatry, 2012Co-Authors: Mirjana Graovac, Jelena Rebic, Ana Kastela, Daniela Petric, Tanja FranciskovicAbstract:Introduction The use of antipsychotics in treatment of children and adolescents requires good knowledge of psychopathology, psychofarmacotherapy, developmental processes and family relations. The combination of clinical experience of those working with psychotic adolescents and a good collaboration with parents, creates a therapeutic space where good results in treatment can be achieved. Objectives The number of antipsychotics registered for use in children and adolescents is quite limited. It is necessary to have parental consent for the use of a medication in this age, with previous explanation of therapeutic goals, limitations and possible side effects of antipsychotics. Methods We present a 14-year old girl adolescent with psychotic symptoms, in which case the course of treatment and discontinuance of therapy was caused by a side effect - an Oculogyric Crisis. Results In the treatment we used a low daily dose of risperidone, a generic medication (1 mg) per os, in the evening. We used generic, not an original medication, respecting recommendations of health sector economy. The effect of the terapy was measured using Clinical Global Impression Scale (CGI) and Brief Psychiatric Rating Scale (BPRS). The daily dose of risperidone wasn‘t elevated. The girl was discharged six days after risperidone was first prescribed. Side effects were not expected. On the way home, the patient experiences Oculogyric Crisis. Conclusions Our clinical presentation indicates that, in spite of low doses of risperidone in generic form, side effects are not excluded, and that wasn‘t noticed when original antipsychotics were used in the same doses.
Frederick W Fraunfelde - One of the best experts on this subject based on the ideXlab platform.
-
Oculogyric Crisis in patients taking cetirizine
American Journal of Ophthalmology, 2004Co-Authors: Frederick W FraunfeldeAbstract:Abstract Purpose To report Oculogyric Crisis in patients receiving cetirizine and inform clinicians on the characteristics of this drug-induced ocular side effect. Methods For this retrospective, observational case series, case reports were collected from the National Registry of Drug-Induced Ocular Side Effects (Casey Eye Institute, Portland, Oregon). The World Health Organization Causality Assessment Guide of Suspected Adverse Reactions was used to categorize the cases. Results Nine cases were reported, with eight occurring in the pediatric age group. Dosage ranged from 5 to 10 mg orally and onset of symptoms ranged from 3 to 184 days. Six cases of Oculogyric Crisis had positive rechallenge data. Eight cases had complete neurologic consultation including radiographic studies. Conclusions Cetirizine can cause Oculogyric Crisis, especially in the pediatric age group. Extensive neurologic workups may be avoided if clinicians recognize this drug-induced ocular side effect.
Zeliha Yaza - One of the best experts on this subject based on the ideXlab platform.
-
Oculogyric Crisis in a patient taking metoclopramide
Clinical Ophthalmology, 2014Co-Authors: Yara Koba, Meti Ekinci, Halil Huseyi Cagatay, Zeliha YazaAbstract:Oculogyric Crisis is an acute dystonic reaction of the ocular muscles characterized by bilateral dystonic elevation of visual gaze lasting from seconds to hours. This reaction is most commonly explained as an adverse reaction to drugs such as antiemetics, antipsychotics, antidepressants, antiepileptics, and antimalarials. Although the incidence of metoclopramide-induced acute dystonic reactions has been reported as 25% in children, there have been few published cases on Oculogyric Crisis in general. It is important to be able to recognize this ocular side effect because, without a thorough patient history, symptoms can be confused with other diseases such as versive seizures, paroxysmal tonic upward gaze, and encephalopathy. In this paper, we report a case of Oculogyric Crisis induced by metoclopramide.
